Pentoxifylline treatment of mice with chronic pulmonary tuberculosis accelerates the development of destructive pathology

Immunology

Volumn 102, Issue 2, 2001, Pages 248-253

  Turner, J ^a   Frank, A A ^a   Brooks, J V ^a   Marietta, P M ^a   Orme, I M ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PENTOXIFYLLINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; HOST RESISTANCE; LUNG INJURY; LUNG TUBERCULOSIS; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CHEMOKINE CCL2; CHRONIC DISEASE; DISEASE PROGRESSION; FEMALE; INTERFERON TYPE II; LUNG; MICE; MICE, INBRED C57BL; PENTOXIFYLLINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035105814     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2001.01161.x     Document Type: Article

References (20)

1. Cytokine/chemokine cascades in immunity to tuberculosis
2. Production of TNF-alpha, IL-6 and TGF-beta, and expression of receptors for TNF-alpha and IL-6, during murine Mycobacterium avium infection
3. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection
4. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin
5. Role of tumor necrosis factor-alpha in Mycobacterium-induced granuloma formation in tumor necrosis factor-alpha-deficient mice
6. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice
7. Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis
8. Production of Interleukin-6 by human and murine mononuclear leukocytes stimulated with Plasmodium antigens is enhanced by Pentoxifylline, and tumor necrosis factor secretion is reduced
9. Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline
10. Anti-tumor necrosis factor antibodies inhibit the influx of granulocytes and monocytes into an inflammatory exudate and enhance the growth of Listeria monocytogenes in various organs
11. Effects of turnout necrosis factor and related cytokines on vascular endothelial cells
12. Pentoxifylline inhibits adhesion and activation of human T lymphocytes
13. Lymphocyte-dependent inhibition of growth of virulent Mycobacterium tuberculosis H37Rv within human monocytes: Requirement for CD4+ T cells in purified protein derivative-positive, but not in purified protein derivative-negative subjects
14. Chemokine response in mice infected with Mycobacterium tuberculosis
15. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages
16. Growth inhibition of Mycobacterium bovis by IFN-γ stimulated macrophages: Regulation by endogenous tumor necrosis factor-α and by IL-10
17. Local production of tumor necrosis factor and IFN-γ in tuberculosis pleuritis
18. Cytokine patterns in tuberculous and sarcoid granulomas: Correlations with histopathologic features of the granulomatous response
19. Selective increase in plasma tumor necrosis factor-alpha and concomitant clinical deterioration after initiating therapy in patients with severe tuberculosis